Sunday, June 3, 2012

Psychiatric CME Sources Guide

Psychiatric CME Sources Guide


_________________________________________________

http://psychiatryonline.org/index.aspx

http://focus.psychiatryonline.org/journal.aspx?journalid=21

http://www.psychiatry.org/learn/cme/focus

Institute on Psychiatric Services

  • Annual Meeting
  • CME
  • Library & Archives
  • Books and Journals
  • Research & Training
  • Residents & Fellows
  • Medical Students
  • PsychiatryOnline
  • Meetings
  • Discussion Board

  • FOCUS: The Journal of Lifelong Learning in Psychiatry


    800-368-5777


    Need help with your subscription or subscription renewal? Have other questions? Start by reviewing the information below. Need more help? Please use our online feedback form or contact Customer Service:

    Email: PsychiatryOnline@psych.org

    Telephone: 1-800-368-5777 (in the U.S.) or 1-703-907-7322 (outside the U.S.) 9:00 AM to 5:30 PM Eastern Time, Monday through Friday  

     


     








    Winter 2011 | Vol 9, Issue 1 Addiction: Current and Future Treatments
    Spring 2011 | Vol 9, Issue 2 Quality and Professionalism in Psychiatry
    Summer 2011 | Vol 9, Issue 3 Anxiety Disorders
    Fall 2011 | Vol 9, Issue 4 Bipolar Disorder

    Earn up to 40 AMA PRA Category 1 CME Credits™!
    A 2011 subscription to FOCUS also provides ABPN approved Performance in Practice Modules that meet requirements for MOC Part IV and an opportunity to earn an additional 20 CME credits.

    Maintenance of Certification (MOC) Resources

    The APA offers a variety of recertification resources to help you incorporate the MOC process into your continuing education, as well as prepare you for the ABPN board exam. Click on each product below for more information.






    MOC Component
    APA Resource
    Credit(s)
    Cost
    Self-Assessment
    FOCUS Self-Assessment 24FOCUS Subscription 800.368.5777
    2012 APA Annual Meeting Self-Assessment in Psychiatry - Available until May 30, 20128Free to Annual Meeting Registrants $100 Members/ $200 Non-Members
    FOCUS MOC Workbook, Self-Assessment in Major Depressive Disorder** - Available in June12TBD
    eFOCUS Program (sent via email)Up to 8 hrs per yearFOCUS Subscribers- Free APA Members - Free
    Performance in Practice (PIP)
    Physician Practice Assessment Tool for Screening of Adults with Substance Use Disorder - Available Now in FOCUS & online20FOCUS Subscribers - Free APA Members - Free
    Non-members - $399
    Physician Practice Assessment Tool for Assessment and Treatment of Adults with Substance Use Disorder -Available Now in FOCUS & online20FOCUS Subscribers - Free APA Members - Free
    Non-members - $399
    Physician Practice Assessment Tools for Assessment and Treatment of Adults at Risk for Suicide and Suicide-Related Behaviors -Available now in FOCUS & online 20FOCUS Subscribers - Free APA Members - Free
    Non-members - $399
    Physician Practice Assessment Tool for the Care of Patients with a Diagnosis of Schizophrenia -Available now in FOCUS & online summer 201220FOCUS Subscribers - Free APA Members - Free
    Non-members - $399
    Physician Practice Assessment Tool for the Care of Patients with Major Depressive Disorder -Available in print (MOC Workbook)** in June & online Fall 201220FOCUS Subscribers –Free APA Members - Free
    Non-members - $399
    Pricing TBD - FOCUS MOC Workbook
    Examination Preparation
    FOCUS Psychiatry Review Volume 2 50Non-members - $65 APA Members - $52 Members-in-Training – $48.75
    FOCUS Psychiatry Review 50Non-members - $65 APA Members - $52 Members-in-Training – $48.75
















    Continue your lifelong learning with ONE trusted resource

    FOCUS is the complete system to meet the requirements of Lifelong Learning, Maintenance of Certification, Self-Assessment and Performance in Practice. FOCUS is available in print and online. Subscribers receive unlimited online access to past volumes at no extra charge. There is no easier, more reliable approach to continuing psychiatric education.


    Lifelong Learning

    FOCUS is a system of lifelong learning written by experts in the field that addresses the core content in psychiatry and provides a comprehensive review of current clinical practice for each featured topic. A CME quiz is provided in each issue. Earn up to 20 hours of CME per year.

    Self-Assessment

    Discover your strengths and areas for improvement with the FOCUS Self-Assessment. Receive a 120-question, multiple-choice, ABPN-approved, self-assessment exam (MOC Part 2) with critique and reference companion for an additional 24 CME credits.

    Performance in Practice (PIP)

    FOCUS includes PIP Modules approved by ABPN for the clinical chart review component of MOC Part 4. Completion of stages A, B, and C provides 20 additional CME credits.

    MOC

    FOCUS is the best program to help you prepare for recertification and complete MOC requirements:












  • ABPN-approved Self-Assessment
  • ABPN-approved PIP modules
  • CME Credit
  • ___________________________________________________

    2012 APA Annual Meeting On Demand and Free new iPad offer                                                                                                           

    Click Here for Details
    96 hours 

    2012 Annual Meeting

    165th Annual Meeting
    May 5-9, 2012
    Philadelphia, PA














    Certificate of Attendance

    Thank you for attending the Annual Meeting 2012. Obtain your Certificate of Attendance and complete the General Evaluation.













    APA ANNUAL MEETING sCIENTIFIC PROGRAM

    Select the APA Meetings Guide for a complete schedule of the meeting. Select Course Brochure to review the descriptions and costs for the courses that were offered. Refer to the Session Highlights that were planned for the meeting: courses, lectures, workshops, and special sessions.

    APA GIVES BACK TO PHILADELPHIA

    The APA made a donation of over $13,000 to the Philadelphia Mental Health Center. This health center is available to children, adolescents, adults, and families in the greater Philadelphia area. They offer individual and family therapy, marital and couples therapy, psychiatric services and medication management, as well as psychological testing and evaluation. PMHC’s goal is to improve the social conditions by offering quality treatment and therapy to those affected by mental illnesses who find themselves without the proper resources. For more information, visit Philadelphia Mental Health Center.  

    LOOKING FOR SESSION INFORMATION FOR THE APA 2012 ANNNUAL MEETING?

    CLICK BELOW IMAGE TO DOWNLOAD .PDF
    Guide_Cover.jpg NIAAA_Cover.jpg NIDA_COVER.jpg
    PROGRAM GUIDENIAAA BROCHURENIDA BROCHURE
    COURSE BROCHURELECTURER BROCHUREETHICS BROCHURE
    SYLLABUS BOOKMILITARY BROCHURENEW RESEARCH BOOK


    NEW!! You can now view the 2012 Annual Meeting Program Guide!!

    DOWNLOAD THE .PDF VERSION OF THE GUIDE
    Open publication






    PRESENTING A POSTER AT THE 2012 APA ANNUAL MEETING?

    DOWNLOAD THE POSTER GUIDELINES

    CONTINUING MEDICAL EDUCATION

    The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    The APA designates this live activity [The 165th Annual Meeting] for a maximum of 50 AMA PRA category 1 credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    ___________________________________________________

    2011


    ___________________________________________________

    http://www.sessions2view.com/apa_library_2010/



    2010 APA Annual Meeting Online -
    DVD-ROM and Online content summary*
    Saturday, May 22
    ISS 01New Developments in Schizophrenia Research and Practice: From the Pipeline to the Clinic
    Lecture 01Translational Research in Schizophrenia: Challenges and Promises
    Lecture 02The Future of Depression Research
    Presidential Symposium 1The Emerging Neurobiology of Antidepressant Treatment Response
    Symposium 002Recent Research on Eating Disorders
    Symposium 006Update on Treatments for Child and Adolescent Eating Disorders
    Symposium 007Neurodevelopmental Disorders in DSM-V: An Update from the Work Group
    Symposium 009Advances in the Management of Treatment-Resistant Depression
    Symposium 012Anxiety Treatment: New Research Findings for the Clinician
    Symposium 015Spirituality and Mental Health: What is the Psychiatrist's Role?
    Symposium 020Updating the APA Guidelines for the Treatment of Borderline Personality Disorder
    Symposium 027Non Psychotic Issues of Schizophrenic Patients
    Symposium 029Executive Function as a Brain System for Self-Control: The Neurocircuitry of Psychiatric Disorders and Addiction
    Symposium 030Addiction Research, Prevention and Treatment in the U.S. and France: Vive la Difference!
    Sunday, May 23
    Lecture 03Manfred S. Guttmacher Award Lecture: Patient Violence Against Mental Health Clinicians: Safety Assessment and Prevention
    Symposium 031Understanding Personality Disorders in Children and Adolescents: Current Status and Future Directions
    Symposium 032Treatment of Depression in Ethnic Minorities
    Symposium 033Approaches to Schizophrenia Through Phases of the Illness
    Symposium 034Diagnosing and Treating the Narcissistic Personality Disorder: Awaiting DSM-5
    Symposium 035Sex/Gender Differences and Women-Specific Issues in Drug Abuse: Predicting and Improving Treatment Outcomes
    Symposium 036Treating Chronic Pain and Co-Occuring Addiction in Substance Abuse Patients
    Symposium 037Culturally Sensitive Treatment of Psychologically Distressed Ethnic and Non-English Speaking Populations
    Symposium 038Neuroendocrine and Neuroimmunological Correlates of Bipolar Disorder in Women
    Symposium 039The Medical Home: Is There a Place for Psychiatry in it?
    Symposium 040Privacy in Electronic Medical Records
    Monday, May 24
    Advances In Series 02Advances in Psychosomatic Medicine
    Advances In Series 04Advances in Psychotherapeutic Treatments
    Advances in Medicine 02Top 10 Medical Articles of 2009: A Comprehensive and Practical Review of What We Need to Know
    FocusFocus Live 1 - Psychotherapy
    ISS 02Novel Approaches to Assessing and Treating Depression in the Medically-Ill
    Lecture 04APA/NIMH Vestermark Award Lecture - Why I Teach - Glen Gabbard, M.D.
    Lecture 05Distinguished Psychiatrist Lecture - The Perplexities & Provocations of Eating Disorders - Katherine Halmi, M.D.
    Lecture 06Optogenetics - Development and Application - Karl Deisseroth, M.D., Ph.D.
    Lecture 08Adolf Meyer Award Lecture - The Audacity Principle in Science?
    Lecture 10The Simple Truth About the Genetic Complexity of Schizophrenia
    Presidential Symposium 2Comparative Effectiveness of Psychotropic Drugs: What Can We Learn from Practical Clinical Trials?
    Presidential Symposium 3Can Basic and Translational Neuroscience Improve Treatment in Psychiatry?
    Symposium 049Advances in the Treatment of Bipolar Disorder
    Symposium 053Genotypes and Biomarkers: The New Decision Makers for Tailored Treatment
    Symposium 059Neurobiology of Obesity: Why We Can Get Too Motivated to Eat
    Tuesday, May 25
    Advances In Series 08Advances In Personality Disorders
    Advances in Medicine 03Movement Disorders in Psychiatric Patients
    Lecture 13From Circuits to Cells to Molecular Regulation: Identifying Novel Targets for the Treatment of Psychotic Disorders
    Lecture 14Co-Morbidity of Psychiatric Disorders
    Lecture 15Highlights and Lessons from 40 Years in Psychiatry
    Lecture 16New Directions in Drug Policy: President Obama’s National Demand Reduction Priorities - Special Guest Lecture, National Institute on Drug Abuse
    Lecture 18Prevention Initiatives in Schizophrenia
    Lecture 19Depression and Suicidal Behavior in Latino Populations - Simon Bolivar Award Lecture
    Presidential Symposium 4Recent Advances in Psychiatric Genetics: From Fundamental Discovery to Clinical Implication
    Symposium 065DSM-5 Examined: Nosology of Mood Disorders
    Symposium 068Reward Neurocircuitry in Substance Dependence and Other Psychiatric Disorders: What Does Brain Research Tell Us?
    Symposium 070Evidence-Based Treatments (EBT) for Borderline Personality Disorder: Empirical Clarity Meets Clinical Reality
    Symposium 074The Treatment of Psychiatric Disorders with rTMS: New Research and Clinical Findings
    Symposium 079The Challenge of Cognitive Enhancers in Medicine
    Wednesday, May 26
    Lecture 20Administrative Psychiatry Award Lecture - So You Want to be a Physician Executive - Arthur Lazarus, M.D., M.B.A.
    Lecture 21Seek and Treat for Optimal Prevention of HIV/AIDS: STOP HIV/AIDS - Julio Montaner, M.D.
    Symposium 086How Dysfunction of Learning and Memory Circuits Contribute to Substance Abuse and Other Psychiatric Disorders
    Symposium 088ADHD FAQs: Practical Answers for the Office-Based Practicioner
    Symposium 089Autonomy in the Prolongation and Curtailment of Life
    Symposium 090New Perspectives on Intergenerational Transmission of BPD
    Symposium 100Dysfunctions in Mentalization or Metacognition in Personality Disorders: Empirical Evidence and Implications for Pathology, Treatment and Research
    Symposium 103Comprehensive HIV Psychiatry Update
    Symposium 104Understanding Comorbidity of Heart Disease With Depression and Anxiety Disorders
    Symposium 105The Ethics of Innovative Interventions in Psychiatry
    *Tentative content. Subject to change.
    Industry-Supported Symposia will be available ONLINE only
    CME credit for all programs available online.
    Individual sessions will be available as audio MP3 file downloads post-meeting at www.marathonmultimedia.com/store/apaThe American Psychiatric Association is accredited by the ACCME to provide continuing medical education for physicians. you may have. The APA designates each of the sessions in this educational activity for a maximum of 1-3 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    2010 APA Annual Meeting -
    Audio DVD-ROM content summary*
    Saturday, May 22
    Lecture 01Translational Research in Schizophrenia: Challenges and Promises
    Lecture 02The Future of Depression Research
    Presidential Symposium 1The Emerging Neurobiology of Antidepressant Treatment Response
    Seminar 01Managing Malpractice Risk for Psychiatrists: The Basics and Beyond
    Seminar 02Evidence-Based Psychotherapy for Chronic Major Depression
    Seminar 03Managing Malpractice Risk for Psychiatrists: The Basics and Beyond
    Seminar 04Infidelity and Marital Relationships: Death Knell or Wake-up Call?
    Symposium 001PTSD in Military Populations: Translating Research Into Practice
    Symposium 002Recent Research on Eating Disorders
    Symposium 003Smoking and Psychiatric Disorders: Clues About Causal Pathways and Innovative Treatment Approaches
    Symposium 004Shared Decision Making in Mental Health Care: A Recovery and Person-Centered Approach
    Symposium 005New Developments in Interpersonal Psychotherapy (IPT)
    Symposium 006Update on Treatments for Child and Adolescent Eating Disorders
    Symposium 007Neurodevelopmental Disorders in DSM-5: An Update from the Work Group
    Symposium 008Aggressive Behaviors in Geropsychiatric Patients: Neurobiology, Assessment and Management
    Symposium 009Advances in the Management of Treatment-Resistant Depression
    Symposium 010Clinical Trends in Bipolar Disorders
    Symposium 011Culturally Sensitive Assessment of Psychologically Distressed Ethnic and Non-English Speaking Populations
    Symposium 012Anxiety Treatment: New Research Findings for the Clinician
    Symposium 013Family and Behavioral Genetic Studies of Borderline Personality Disorder
    Symposium 014Examining the Outcome Continuum of Schizophrenia Into Later Life
    Symposium 015Spirituality and Mental Health: What is the Psychiatrist's Role?
    Symposium 016Burn Psychiatry: Treatment and Outcomes
    Symposium 017Update on Interventions for Adult Eating Disorders
    Symposium 018Translating the Psychopharmacology Evidence Base Into Practice: A Sampler From the American Society of Clinical Psychopharmacology
    Symposium 019Pathophysiology of Psychotic and Mood Disorders: Do We Have any Solid Evidence of Interest to Clinicians?
    Symposium 020Updating the APA Guidelines for the Treatment of Borderline Personality Disorder
    Symposium 021How to Get the Corner Office: Practical Leadership Strategies for Women Psychiatrists
    Symposium 022Culture and Psychiatric Diagnosis: Implications for the International Impact of DSM-5
    Symposium 023Recent Changes to Acute Psychiatric Care: An International Perspective
    Symposium 024Prevention of PTSD: Recent Israeli Practices
    Symposium 025Psychiatry Across Borders: Working for the U.S. Government in the Department of State as a Psychiatrist
    Symposium 026Transcultural Psychiatry for Mental Health in a Changing World
    Symposium 027Non Psychotic Issues of Schizophrenic Patients
    Symposium 028Doping in Athletes: The Role of the Sport Psychiatrist
    Symposium 029Executive Function as a Brain System for Self-Control: The Neurocircuitry of Psychiatric Disorders and Addiction
    Symposium 030Addiction Research, Prevention and Treatment in the U.S. and France: Vive la Difference!
    Sunday, May 23
    Lecture 03Manfred S. Guttmacher Award Lecture: Patient Violence Against Mental Health Clinicians: Safety Assessment and Prevention
    Scientific and Clinical Report 02Mood Disorders
    Scientific and Clinical Report 03Psychpharmacology
    Scientific and Clinical Report 04Child and Adolescent Psychiatry
    Scientific and Clinical Report 05Psychosomatic Medicine and Health Services Research
    Seminar 05The IMG Institute
    Seminar 06Overview of Recovery for Psychiatrists
    Symposium 031Understanding Personality Disorders in Children and Adolescents: Current Status and Future Directions
    Symposium 032Treatment of Depression in Ethnic Minorities
    Symposium 033Approaches to Schizophrenia Through Phases of the Illness
    Symposium 034Diagnosing and Treating the Narcissistic Personality Disorder: Awaiting DSM-5
    Symposium 035Sex/Gender Differences and Women-Specific Issues in Drug Abuse: Predicting and Improving Treatment Outcomes
    Symposium 036Treating Chronic Pain and Co-Occuring Addiction in Substance Abuse Patients
    Symposium 037Culturally Sensitive Treatment of Psychologically Distressed Ethnic and Non-English Speaking Populations
    Symposium 038Neuroendocrine and Neuroimmunological Correlates of Bipolar Disorder in Women
    Symposium 039The Medical Home: Is There a Place for Psychiatry in it?
    Symposium 040Privacy in Electronic Medical Records
    Monday, May 24
    Advances In Medicine 01Delirium: Neurobiology, Prevention and Treatment Approaches
    Advances In Medicine 02Top 10 Medical Articles of 2009: A Comprehensive and Practical Review of What We Need to Know
    Advances In Research 01Advances in Research
    Advances In Series 01Advances in Correctional Psychiatry: From Provision of Care to Malpractice Prevention
    Advances In Series 02Advances in Psychosomatic Medicine
    Advances In Series 03Advances in Forensic Psychiatry
    Advances In Series 04Advances in Psychotherapeutic Treatments
    FocusFocus Live 1 - Psychotherapy
    Forum 01Chopin at 200: His Mind and His Music
    Forum 02DSM-5: Progress in Research and Development
    Lecture 04APA/NIMH Vestermark Award Lecture - Why I Teach - Glen Gabbard, M.D.
    Lecture 05Distinguished Psychiatrist Lecture - The Perplexities & Provocations of Eating Disorders - Katherine Halmi, M.D.
    Lecture 06Optogenetics - Development and Application - Karl Deisseroth, M.D., Ph.D.
    Lecture 07Neuroimaging Clue to the Causes of Bipolar Disorder: Where We Are and Where We’re Going - Distinguished Psychiatrist Lecture
    Lecture 08Adolf Meyer Award Lecture - The Audacity Principle in Science?
    Lecture 09“Your Bipolar Dad Is a Bad Reason to Become a Psychiatrist”: Advocacy Adventures of a Bewildered Boy who Grew up to Become NAMI’s Medical Director - Patient Advocacy Award Lecture
    Lecture 10The Simple Truth About the Genetic Complexity of Schizophrenia
    Lecture 11Solomon Carter Fuller: What Would He Say about Racial Politics in American Psychiatry Today? Solomon Carter Fuller Award Lecture
    Presidential Symposium 2Comparative Effectiveness of Psychotropic Drugs: What Can We Learn from Practical Clinical Trials?
    Presidential Symposium 3Can Basic and Translational Neuroscience Improve Treatment in Psychiatry?
    Scientific and Clinical Report 06Psychotherapy and Depression
    Scientific and Clinical Report 07Borderline Personality Disorder and Emotion Dysregulation
    Scientific and Clinical Report 08Borderline Personality Disorder
    Scientific and Clinical Report 09Childhood Abuse
    Scientific and Clinical Report 10Cognitive Disorders
    Scientific and Clinical Report 11Diagnostic Issues and DSM-5
    Scientific and Clinical Report 12Psychosomatics and Cardiac Vulnerability
    Scientific and Clinical Report 13Addictive Behavior
    Symposium 041Health and Mental Health Around the World: Are all Systems Go?
    Symposium 042Update on Medications Development: Promising New Treatments for Drug Addiction
    Symposium 043Early Detection and Intervention in Schizophrenia: An Idea Whose Time has Come
    Symposium 044An Examination of CNS Trial Methodologies
    Symposium 045 INVITEDInterpersonal and Social Rhythm Therapy (IPSRT) for Bipolar Disorder: New Applications, New Populations, and New Evidence
    Symposium 046Ensuring a Public Health Impact: Partnering With Consumers and Community Stakeholders to Improve Access and Quality of Care for Mental Disorders
    Symposium 047New Studies to Appear in the June Issue of the American Journal of Psychiatry: Presentations by the Authors and Editors
    Symposium 048Reducing Harm: SaferInjection and Other Strategies
    Symposium 049Advances in the Treatment of Bipolar Disorder
    Symposium 050Challenges in Providing Mental Health Care for College and University Students
    Symposium 051Geriatric Psychopharmacology of Late-Life Mood Disorders: Focus on the use of Biomarkers as Predictors of Response
    Symposium 052Innovations in Integrated Treatment of Substance Use and Psychiatric Disorders
    Symposium 053Genotypes and Biomarkers: The New Decision Makers for Tailored Treatment
    Symposium 054Substance Related Disorders in DSM-5: Progress Report
    Symposium 055DSM-5 Update Series, Part I: Reports From the Work Groups
    Symposium 056Focal Brain Stimulation for Psychiatric Disorders: Clinical Update
    Symposium 057Depression, Metabolic Syndrome and Obesity
    Symposium 059Neurobiology of Obesity: Why We Can Get Too Motivated to Eat
    Tuesday, May 25
    Advances in Medicine 03Movement Disorders in Psychiatric Patients
    Advances In Medicine 04AM04 Aging and Dementia: An Update on Neuroscience
    Advances In Medicine 05Medical Mysteries and Practical Medical Psychiatric Updates: Is It Medical, Psychiatric, or a Little of Both?
    Advances In Series 05Family Assessment and Intervention for Psychiatrists
    Advances In Series 06Advances in the Use of Antipsychotic Medications
    Advances In Series 07Advances in Substance Abuse Treatment
    Advances In Series 08Advances In Personality Disorders
    Forum 03Is a Game-Changing Psychotropic Too Much to Expect?
    Forum 04Global Disasters: Lessons Learned from Haiti & New Orleans
    Lecture 12Addiction: Conflict Between Brain Circuits
    Lecture 13From Circuits to Cells to Molecular Regulation: Identifying Novel Targets for the Treatment of Psychotic Disorders
    Lecture 14Co-Morbidity of Psychiatric Disorders
    Lecture 15Highlights and Lessons from 40 Years in Psychiatry
    Lecture 16New Directions in Drug Policy: President Obama's National Demand Reduction Priorities - Special Guest Lecture, National Institute on Drug Abuse
    Lecture 17Toward a New Psychiatry: Valuing the Positive Emotions
    Lecture 18Prevention Initiatives in Schizophrenia
    Lecture 19Simon Bolivar Award Lecture - Depression and Suicidal Behavior in Latino Populations
    Presidential Symposium 4Recent Advances in Psychiatric Genetics: From Fundamental Discovery to Clinical Implication
    Presidential Symposium 85Health Reform and Psychiatry
    Scientific and Clinical Report 14Anxiety Disorders
    Scientific and Clinical Report 15Information Technology
    Scientific and Clinical Report 16SCR16-Side Effects of Psychotropic Medication
    Scientific and Clinical Report 17Weight Gain and Psychiatric Illness
    Scientific and Clinical Report 18Suicide
    Scientific and Clinical Report 19Attention Deficits and Psychostimulants
    Scientific and Clinical Report 20Inpatient Psychiatry: Admissions and Readmissions
    Scientific and Clinical Report 21Scales and Screening Measure
    Symposium 060The Potential and Pitfalls of Creating a Bipolar Genomic Biobank
    Symposium 061Psychiatrists in the World: Advocating for LGBT Mental Health
    Symposium 062The Public Health and Clinical Interface Between HIV, STDs, and Mental Health
    Symposium 063Adolescent Potential: Exploring the Developing Brain and Understanding Pathways of Addiction
    Symposium 064The 2010 APA Task Force Report on the Practice of Electroconvulsive Therapy: Evidence Based Guidelines for the Practicing Clinician
    Symposium 065DSM-5 Examined: Nosology of Mood Disorders
    Symposium 066DSM-5 Update Series, Part II: Reports From the Work Groups
    Symposium 067Revisiting Pharmacological Treatments to Prevent Suicide
    Symposium 068Reward Neurocircuitry in Substance Dependence and Other Psychiatric Disorders: What Does Brain Research Tell Us?
    Symposium 069Implementing the STEPPS* Program for Borderline Personality Disorder (*Systems Training for Emotional Predictability and Problem Solving)
    Symposium 070Evidence-Based Treatments (EBT) for Borderline Personality Disorder: Empirical Clarity Meets Clinical Reality
    Symposium 072The Nuts and Bolts of the Perinatal Psychiatric Consultation
    Symposium 074The Treatment of Psychiatric Disorders with rTMS: New Research and Clinical Findings
    Symposium 075The Tattered Safety Net: The Public Mental Health Crisis in an Economic Recession
    Symposium 076Lessons from Hurricane Katrina: Response, Recovery and Rebuilding
    Symposium 077Toward a New Model for Mental Health Services in the University Community
    Symposium 078DSM-5 Update Series, Part III: Reports from the Work Groups
    Symposium 079The Challenge of Cognitive Enhancers in Medicine
    Symposium 080Sex and Psychodynamics: Contemporary Approaches to Clinical Issues Through the Lifecycle
    Symposium 081Progress and Promise: Preventing the First Episode of Psychosis
    Symposium 082Reproductive Issues and Women’s Mental Health: How to Untie the Gordian Knot?
    Symposium 083Treatment of Depression With TMS: An Overview of Findings From the Optimization of TMS for the Treatment of Depression Trial (Opt-TMS)
    Wednesday, May 26
    Advances In Medicine 06An Update on Gastroenterology and Hepatology for Psychiatrists and Mental Health Practitioners
    Lecture 20Administrative Psychiatry Award Lecture - So You Want to be a Physician Executive - Arthur Lazarus, M.D., M.B.A.
    Lecture 21Seek and Treat for Optimal Prevention of HIV/AIDS: STOP HIV/AIDS - Julio Montaner, M.D.
    Scientific and Clinical Report 22Genetics
    Scientific and Clinical Report 23Issues in Child and Adolescent Psychiatry
    Scientific and Clinical Report 24Antidepressant Response and Augmentation
    Scientific and Clinical Report 25Psychopharmacology
    Scientific and Clinical Report 26Psychosis
    Scientific and Clinical Report 27Issues in Mood Disorders
    Scientific and Clinical Report 28Epidemiology, Sleep, and Medical Screening
    Scientific and Clinical Report 29Important but Infrequently Addressed Topics
    Seminar 07Practical Guide to the Performance of the Mental Status Examination
    Symposium 085Women’s Mental Health in Latin America: Present and Future Research
    Symposium 086How Dysfunction of Learning and Memory Circuits Contribute to Substance Abuse and Other Psychiatric Disorders
    Symposium 087Advances in Psychiatric Ethics: New Approaches that Inform Psychiatric Practice
    Symposium 088ADHD FAQs: Practical Answers for the Office-Based Practicioner
    Symposium 089Autonomy in the Prolongation and Curtailment of Life
    Symposium 090New Perspectives on Intergenerational Transmission of BPD
    Symposium 091New CANMAT Guidelines for Depression and Bipolar Disorder: Combining Evidence with Clinical Practice
    Symposium 092Update on Cannabis Use Disorder
    Symposium 093Cultural Adaptation of Cognitive-Behavior Therapy for Ethnic/Minority Patients
    Symposium 094Choosing the Right Treatment for Substance Abuse
    Symposium 095Should “Risk syndrome of Psychosis” be Included in DSM-5 as a Diagnosis? A Road Toward Preventive Psychiatry
    Symposium 096Basic Science in Psychiatry: A Move Toward Translational Medicine
    Symposium 097The Supreme Court and Psychiatry in the 21st Century
    Symposium 098Novel Tools for Preventing and Treating Substance Use and Comorbidities in the Military and Returning Veterans
    Symposium 099Hot Topics in African-American Mental Health: Impact of Past and Current Prejudices; Women’s Mental Health; HIV; and Unique Psychopharmacological Findings
    Symposium 100Dysfunctions in Mentalization or Metacognition in Personality Disorders: Empirical Evidence and Implications for Pathology, Treatment and Research
    Symposium 102Treating Borderline Personality Disorder: Current Psychodynamic Perspectives
    Symposium 103Comprehensive HIV Psychiatry Update
    Symposium 104Understanding Comorbidity of Heart Disease With Depression and Anxiety Disorders
    Symposium 105The Ethics of Innovative Interventions in Psychiatry
    *Tentative content. Subject to change.
    Individual sessions will be available as audio MP3 file downloads post-meeting at www.marathonmultimedia.com/store/apa

    _________________________________________________

    AMA
    Health Information Technology

    *
    For more than 30 years, Massachusetts General Hospital has been a leader in educating mental health professionals, and the Psychiatry Department ranks #1 in US News & World Report's Survey of America's Best Hospitals for a 16th consecutive year.
    *
    ______________________________________________


    www.abpn.com

    Maintenance of Certification in Psychiatry 

    The ABPN MOC Program reflects the Board’s commitment to lifelong learning throughout one’s profession. The mission of the ABPN's Maintenance of Certification (MOC) Program is to advance the clinical practice of psychiatry by promoting the highest evidence-based guidelines and standards to ensure excellence in all areas of care and practice improvement.

    Apply for an examination | ABPN Physician Folios site | Visit the Pearson VUE Website


    Maintenance of Certification in Psychiatry


    The Maintenance of Certification Program (MOC) of the American Board of Psychiatry and Neurology reflects the Board's commitment to lifelong learning throughout one's profession. The mission of MOC is to ensure that diplomates adhere to the highest standards in medicine and pursue excellence in all areas of care and practice improvement. The MOC program requires diplomates to participate in sanctioned self-assessment performance measures, identify perceived weaknesses in their knowledge, pursue learning activities tailored to areas that need to be strengthened, and develop quality improvement programs based on their clinical practice. The goal is for diplomates to reflect on their personal knowledge and performance and commit to a process of improvement and reevaluation of performance measures over a specified time frame that will ultimately lead to improved care for their patients. [more]
    MOC Approved* Products: CME, Self Assessment, and PIP
    *Approved products have been reviewed by the ABPN and have been shown to satisfy the criteria for MOC activities. Other activities that satisfy those criteria, but have not been approved by the ABPN may also be used to fulfill the MOC requirements. For a full list of the MOC activity requirements, click here to visit our Maintenance of Certification overview page. Beginning in 2014, diplomates are required to use only ABPN-approved products for Self-Assessment and Performance in Practice activities.

    ABPN Approved CME Product List
    OrganizationProduct
    American Medical Association AMA Direct Credit for AMA PRA Category 1 Credit�ABMS member board certification and Maintenance of Certification (MOC)
    American Physician Institute CME to Go
    American Psychiatric Association 2012 Annual Meeting Self-Assessment in Psychiatry
    American Psychiatric Association Clinical eFocus (sent by email to all APA members)
    American Psychiatric Association Focus Self Assessment
    American Psychiatric Association Performance in Practice for Comprehensive Assessment for Suicide and Suicide-Related Behaviors
    American Psychiatric Association Performance in Practice Physician Assessment Module for the Assessment and Treatment of Adults with Substance Use Disorder
    American Psychiatric Association Performance in Practice Physician Assessment Module for the Screening of Adults with Substance Use Disorder
    Audio-Digest Foundation MOC Self-Assessment Module: Mood Disorders/Bipolar Disorder
    Audio-Digest Foundation MOC Self-Assessment Module: Mood Disorders/Major Depressive Disorder
    Carlat Publishing The Carlat Psychiatry Report
    CME Outfitters Chart Review: Clinical Challenges in the Management of Patients with Alzheimer's Disease
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � ADHD MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Anxiety MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Mood Disorders I MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Mood Disorders II MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Psychosis MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Substance Use Disorders MOC Self-Assessment Module
    Mayo School of Continuous Professional Development Acute Care Psychiatry Clinical Review
    Med-IQ Performance Improvement Strategies in Clinical Depression
    Med-IQ Performance Improvement Strategies in Multiple Sclerosis
    Neuroscience Education Institute NEI Approved Self-Assessment Activities
    Neuroscience Education Institute Stahl's Self-Assessment Examination in Psychiatry: Multiple Choice Questions for Clinicians
    Oakstone Medical Publishing Psychiatry Board Review Course Enduring DVD
    Oakstone Medical Publishing Psychiatry Board Review Course Live
    Physicians Postgraduate Press Bipolar Disorder Self-Assessment
    PVI, PeerView Institute for Medical Education Measurement-Based Approaches for Achieving and Maintaining Remission in Adults With Major Depressive Disorder
    University of Wisconsin - School of Medicine NOW Coalition for Bipolar Disorder
    University of Wisconsin - School of Medicine Performance Improvement - Tobacco Cessation


    ABPN Approved Self Assessment Product List
    OrganizationProduct
    American Academy of Psychiatry and the Law (AAPL) Forensic Psychiatry Self Assessment
    American Physician Institute CME to Go
    American Psychiatric Association 2012 Annual Meeting Self-Assessment in Psychiatry
    American Psychiatric Association Clinical eFocus (sent by email to all APA members)
    American Psychiatric Association Focus Self Assessment
    Audio-Digest Foundation MOC Self-Assessment Module: Mood Disorders/Bipolar Disorder
    Audio-Digest Foundation MOC Self-Assessment Module: Mood Disorders/Major Depressive Disorder
    Carlat Publishing The Carlat Psychiatry Report
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � ADHD MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Anxiety MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Mood Disorders I MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Mood Disorders II MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Psychosis MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Substance Use Disorders MOC Self-Assessment Module
    Neuroscience Education Institute NEI Approved Self-Assessment Activities
    Neuroscience Education Institute Stahl's Self-Assessment Examination in Psychiatry: Multiple Choice Questions for Clinicians
    Physicians Postgraduate Press Bipolar Disorder Self-Assessment
    The American College of Psychiatrists Psychiatrists in Practice Exam (PIPE)
    University of Wisconsin - School of Medicine NOW Coalition for Bipolar Disorder
    University of Wisconsin - School of Medicine Performance Improvement - Tobacco Cessation


    ABPN Approved PIP Clinical Product List
    OrganizationProduct
    American Academy of Psychiatry and The Law (AAPL) Performance in Practice Checklist: AAPL Guideline on Competence To Stand Trial
    American Academy of Psychiatry and the Law (AAPL) Performance in Practice Checklist: AAPL Guideline on Disability Evaluation
    American Psychiatric Association Performance in Practice for Comprehensive Assessment for Suicide and Suicide-Related Behaviors
    American Psychiatric Association Performance in Practice Physician Assessment Module for the Assessment and Treatment of Adults with Substance Use Disorder
    American Psychiatric Association Performance in Practice Physician Assessment Module for the Screening of Adults with Substance Use Disorder
    American Psychiatric Association Performance in Practice Physician Practice Assessment Tool for the Care of Patients with a Diagnosis of Schizophrenia
    Cleveland Clinic PIP Clinical Module in Clinical Neurophysiology
    CME Outfitters Chart Review: Clinical Challenges in the Management of Patients with Alzheimer's Disease
    Med-IQ Performance Improvement Strategies in Clinical Depression
    Med-IQ Performance Improvement Strategies in Multiple Sclerosis
    PVI, PeerView Institute for Medical Education Measurement-Based Approaches for Achieving and Maintaining Remission in Adults With Major Depressive Disorder
    University of Wisconsin - School of Medicine NOW Coalition for Bipolar Disorder
    University of Wisconsin - School of Medicine Performance Improvement - Tobacco Cessation


    ABPN Approved PIP Feedback Product List
    OrganizationProduct
    American Board of Psychiatry and Neurology ABPN Patient Feedback Form
    American Board of Psychiatry and Neurology ABPN Peer Feedback Form
    Med-IQ Performance Improvement Strategies in Clinical Depression
    Med-IQ Performance Improvement Strategies in Multiple Sclerosis
    Sanford Health Survey Sanford Health - Patient Review
    University of Wisconsin - School of Medicine NOW Coalition for Bipolar Disorder
    University of Wisconsin - School of Medicine Performance Improvement - Tobacco Cessation

    *
    Clinically Active Status

    The American Board of Medical Specialties (ABMS) has issued definitions of "Clinically Active" and "Clinically Inactive" and requires that all diplomates self-report their status once every 24 months in each area of certification. This information will be available to the public.

    1. "Clinically Active": Any amount of direct and/or consultative patient care has been provided in the preceding 24 months. This includes the supervision of residents.
    A. Engaged in direct and/or consultative care sufficient to complete Performance-in-Practice (PIP) Units.
    B. Engaged in direct and/or consultative care not sufficient to complete PIP Units.

    2. "Clinically Inactive": No direct and or/consultative patient care has been provided in the past 24 months.

    3. "Status Unknown": No information available on the clinical activity of this diplomate.

    Diplomates who are in category 1.A. are required to complete all components of the MOC Program including PIP Units. Diplomates who are in categories 1.B. or 2 are required to complete all components of the MOC Program, except for PIP Units. A change in diplomate status from 1.B. or 2 to 1.A. requires the completion of at least one PIP Unit.

    *

    _________________________________________________

    http://psychiatryonline.org/index.aspx

    http://focus.psychiatryonline.org/journal.aspx?journalid=21

    *
    AMA
    Health Information Technology

    *
    For more than 30 years, Massachusetts General Hospital has been a leader in educating mental health professionals, and the Psychiatry Department ranks #1 in US News & World Report's Survey of America's Best Hospitals for a 16th consecutive year.
    *

    Maintenance of Certification in Psychiatry

    Maintenance of Certification in Psychiatry

    Maintenance of Certification in Psychiatry
    The ABPN MOC Program reflects the Board’s commitment to lifelong learning throughout one’s profession. The mission of the ABPN's Maintenance of Certification (MOC) Program is to advance the clinical practice of psychiatry by promoting the highest evidence-based guidelines and standards to ensure excellence in all areas of care and practice improvement.

    Apply for an examination | ABPN Physician Folios site | Visit the Pearson VUE Website


    Maintenance of Certification in Psychiatry


    The Maintenance of Certification Program (MOC) of the American Board of Psychiatry and Neurology reflects the Board's commitment to lifelong learning throughout one's profession. The mission of MOC is to ensure that diplomates adhere to the highest standards in medicine and pursue excellence in all areas of care and practice improvement. The MOC program requires diplomates to participate in sanctioned self-assessment performance measures, identify perceived weaknesses in their knowledge, pursue learning activities tailored to areas that need to be strengthened, and develop quality improvement programs based on their clinical practice. The goal is for diplomates to reflect on their personal knowledge and performance and commit to a process of improvement and reevaluation of performance measures over a specified time frame that will ultimately lead to improved care for their patients. [more]
    MOC Approved* Products: CME, Self Assessment, and PIP
    *Approved products have been reviewed by the ABPN and have been shown to satisfy the criteria for MOC activities. Other activities that satisfy those criteria, but have not been approved by the ABPN may also be used to fulfill the MOC requirements. For a full list of the MOC activity requirements, click here to visit our Maintenance of Certification overview page. Beginning in 2014, diplomates are required to use only ABPN-approved products for Self-Assessment and Performance in Practice activities.

    ABPN Approved CME Product List
    OrganizationProduct
    American Medical Association AMA Direct Credit for AMA PRA Category 1 Credit�ABMS member board certification and Maintenance of Certification (MOC)
    American Physician Institute CME to Go
    American Psychiatric Association 2012 Annual Meeting Self-Assessment in Psychiatry
    American Psychiatric Association Clinical eFocus (sent by email to all APA members)
    American Psychiatric Association Focus Self Assessment
    American Psychiatric Association Performance in Practice for Comprehensive Assessment for Suicide and Suicide-Related Behaviors
    American Psychiatric Association Performance in Practice Physician Assessment Module for the Assessment and Treatment of Adults with Substance Use Disorder
    American Psychiatric Association Performance in Practice Physician Assessment Module for the Screening of Adults with Substance Use Disorder
    Audio-Digest Foundation MOC Self-Assessment Module: Mood Disorders/Bipolar Disorder
    Audio-Digest Foundation MOC Self-Assessment Module: Mood Disorders/Major Depressive Disorder
    Carlat Publishing The Carlat Psychiatry Report
    CME Outfitters Chart Review: Clinical Challenges in the Management of Patients with Alzheimer's Disease
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � ADHD MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Anxiety MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Mood Disorders I MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Mood Disorders II MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Psychosis MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Substance Use Disorders MOC Self-Assessment Module
    Mayo School of Continuous Professional Development Acute Care Psychiatry Clinical Review
    Med-IQ Performance Improvement Strategies in Clinical Depression
    Med-IQ Performance Improvement Strategies in Multiple Sclerosis
    Neuroscience Education Institute NEI Approved Self-Assessment Activities
    Neuroscience Education Institute Stahl's Self-Assessment Examination in Psychiatry: Multiple Choice Questions for Clinicians
    Oakstone Medical Publishing Psychiatry Board Review Course Enduring DVD
    Oakstone Medical Publishing Psychiatry Board Review Course Live
    Physicians Postgraduate Press Bipolar Disorder Self-Assessment
    PVI, PeerView Institute for Medical Education Measurement-Based Approaches for Achieving and Maintaining Remission in Adults With Major Depressive Disorder
    University of Wisconsin - School of Medicine NOW Coalition for Bipolar Disorder
    University of Wisconsin - School of Medicine Performance Improvement - Tobacco Cessation


    ABPN Approved Self Assessment Product List
    OrganizationProduct
    American Academy of Psychiatry and the Law (AAPL) Forensic Psychiatry Self Assessment
    American Physician Institute CME to Go
    American Psychiatric Association 2012 Annual Meeting Self-Assessment in Psychiatry
    American Psychiatric Association Clinical eFocus (sent by email to all APA members)
    American Psychiatric Association Focus Self Assessment
    Audio-Digest Foundation MOC Self-Assessment Module: Mood Disorders/Bipolar Disorder
    Audio-Digest Foundation MOC Self-Assessment Module: Mood Disorders/Major Depressive Disorder
    Carlat Publishing The Carlat Psychiatry Report
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � ADHD MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Anxiety MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Mood Disorders I MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Mood Disorders II MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Psychosis MOC Self-Assessment Module
    Massachusetts General Hospital Psychiatry Academy MGH Psychiatry � Substance Use Disorders MOC Self-Assessment Module
    Neuroscience Education Institute NEI Approved Self-Assessment Activities
    Neuroscience Education Institute Stahl's Self-Assessment Examination in Psychiatry: Multiple Choice Questions for Clinicians
    Physicians Postgraduate Press Bipolar Disorder Self-Assessment
    The American College of Psychiatrists Psychiatrists in Practice Exam (PIPE)
    University of Wisconsin - School of Medicine NOW Coalition for Bipolar Disorder
    University of Wisconsin - School of Medicine Performance Improvement - Tobacco Cessation


    ABPN Approved PIP Clinical Product List
    OrganizationProduct
    American Academy of Psychiatry and The Law (AAPL) Performance in Practice Checklist: AAPL Guideline on Competence To Stand Trial
    American Academy of Psychiatry and the Law (AAPL) Performance in Practice Checklist: AAPL Guideline on Disability Evaluation
    American Psychiatric Association Performance in Practice for Comprehensive Assessment for Suicide and Suicide-Related Behaviors
    American Psychiatric Association Performance in Practice Physician Assessment Module for the Assessment and Treatment of Adults with Substance Use Disorder
    American Psychiatric Association Performance in Practice Physician Assessment Module for the Screening of Adults with Substance Use Disorder
    American Psychiatric Association Performance in Practice Physician Practice Assessment Tool for the Care of Patients with a Diagnosis of Schizophrenia
    Cleveland Clinic PIP Clinical Module in Clinical Neurophysiology
    CME Outfitters Chart Review: Clinical Challenges in the Management of Patients with Alzheimer's Disease
    Med-IQ Performance Improvement Strategies in Clinical Depression
    Med-IQ Performance Improvement Strategies in Multiple Sclerosis
    PVI, PeerView Institute for Medical Education Measurement-Based Approaches for Achieving and Maintaining Remission in Adults With Major Depressive Disorder
    University of Wisconsin - School of Medicine NOW Coalition for Bipolar Disorder
    University of Wisconsin - School of Medicine Performance Improvement - Tobacco Cessation


    ABPN Approved PIP Feedback Product List
    OrganizationProduct
    American Board of Psychiatry and Neurology ABPN Patient Feedback Form
    American Board of Psychiatry and Neurology ABPN Peer Feedback Form
    Med-IQ Performance Improvement Strategies in Clinical Depression
    Med-IQ Performance Improvement Strategies in Multiple Sclerosis
    Sanford Health Survey Sanford Health - Patient Review
    University of Wisconsin - School of Medicine NOW Coalition for Bipolar Disorder
    University of Wisconsin - School of Medicine Performance Improvement - Tobacco Cessation


    Thursday, May 31, 2012

    Google Reader - Mike Nova's starred items

    Google Reader - Mike Nova's starred items


    via psychiatry - Google Blog Search by unknown on 5/29/12
    Psychiatric Hammer Joel Wade Daily Bell DSM-5 APA Diagnostic Statistical Manual Mental Disorders Thedailybell.com.

    The use of organ extracts to treat psychiatric disorder in the interwar period is an episode in the history of psychiatry which has largely been forgotten. An analysis of case‐notes from The Maudsley Hospital from the period 1923–1938 shows that the prescription of extracts taken from animal ...


    How Psychiatry Mistreats People of Color
    AlterNet
    Research has also shown the black students are disciplined more severely than white students, even when they commit offenses that are less serious. The National Education Policy Center at the University of Colorado reported (PDF) that more than 30 ...

    and more »


    Study: Marijuana Linked to Lower Mortality Rate for Patients with Psychotic ...
    AlterNet
    The use of cannabis is associated with lower mortality risk in patients with schizophrenia and related psychotic disorders, according to a forthcoming study to be published in the Journal of Psychiatric Research. (Read the abstract of the study online ...

    and more »

    via Clinical Psychiatry News by a.ault@elsevier.com on 5/31/12
    They may have come relatively late to the party, but physician-led political action committees have become true players on the political stage and are poised to exert their influence in this year’s...

    Were any more proof needed that APA has forfeited its right to monopoly control of psychiatric diagnosis, this is the smoking gun. Psychiatric diagnosis has become too important to be left in the hands of a small, withering, ...

    This study evaluated the structure and validity of the use of the 18‐item Interpersonal Needs Questionnaire (INQ‐18), a measure of thwarted belongingness (TB) and perceived burdensomeness (PB), among older adults.MethodCommunity‐dwelling older adults (N = 284; mean age = 73 years; age ran...

    via Psychology, Philosophy and Real Life by Gordon Shippey on 5/31/12
    Photo by /\ \/\/ /\ - http://flic.kr/p/6nXcCd
    While optical illusions are fun and familiar, we are discovering other illusions within our own minds that have the power to amaze and upset some of our dearest beliefs about ourselves.
    Tags: , , ,


    'Truman show' delusion: Believing your life is a reality TV show
    msnbc.com
    For example, in this month's issue of the International Journal of Social Psychiatry, researchers from Maywood University studied records from a state psychiatric institution across the last century and found that while the categories of delusions were ...

    Monday, May 28, 2012

    Spitzer Recants: Why Can't APA Admit Mistakes and Correct Them | Psychology Today

    Spitzer Recants: Why Can't APA Admit Mistakes and Correct Them | Psychology Today

    Spitzer Recants: Why Can't APA Admit Mistakes and Correct Them

    New APA leadership is last hope

    Spitzer Recants: Why Can't APA Admit Mistakes and Correct Them

    Ben Carey's front page story in the New York Times movingly recounts Bob Spitzer's apology for an ill-advised study he conducted more than a decade ago.
    http://www.nytimes.com/2012/05/19/health/dr-robert-l-spitzer-note...

    The background is dramatic. Spitzer had been a hero to the gay and lesbian community because he was the person most responsible for removing homosexuality from DSM II. Lifting the cloud of mental disorder from sexual choice was a big step in the civil rights movement that only now is bringing full equality. I once attended an award dinner honoring Bob for his contributions to the gay/lesbian cause. I never saw a group more appreciative or a recipient so proud.

    How surprising then that Spitzer would later publish a methodologically flawed paper suggesting that psychotherapy might have some value in changing sexual orientation. Bob had serious misgivings almost immediately when fundamentalists exploited the paper to pursue their anachronistic agenda. He decided recently to make a very public apology. “I believe I owe the gay community an apology for my study making unproven claims of the efficacy of reparative therapy. I also apologize to any gay person who wasted time and energy undergoing some form of reparative therapy because they believed that I had proven that reparative therapy works with some `highly motivated’ individuals.”

    Let's compare Bob's forthrightness to the consistently evasive stonewalling that has characterized every step in the development of DSM 5. The American Psychiatric Association has a lot to apologize for- but instead maintains a doggedly defensive posture that prevents insight and self correction.

    Bob was the first to point out the absurdity of the DSM 5 confidentiality agreements and to predict the poor results that would come from the resulting secretive and closed process. Each of his dire predictions has turned out to be right on target. DSM 5 badly missed every one of its deadlines- then with time running short, it quietly cancelled its quality control step because publishing profits trumped the public trust of producing a safe product. No apology for that.

    When its field trial results were unacceptably low by historical standards, DSM 5 lowered its standards rather than working to improve its product to meet them. Again no apology.

    DSM 5 persists in offering proposals that would inappropriately inflict the label ‘mental disorder’ on many millions of people now considered normal. These suggestions are unsupported by science and are strongly opposed by 51 mental health associations- but APA continues to refuse demands for independent external review.

    The shabby DSM 5 enterprise has reduced the credibility of psychiatry and the stature of the APA. It may well have forfeited APA's right to continue as custodian of the DSM franchise. Yes, indeed, APA has a lot to apologize for and DSM 5 has a long way to go before it will be safe and scientifically sound.

    But there are two small rays of hope. First, DSM 5 has belatedly dropped its worst proposal- psychosis risk- opening the door to the possibility that it is finally ready to make other much-needed concessions.

    Secondly, the APA leadership changed hands at the recent annual meeting. Perhaps the new leaders will finally bring responsible governance to what has heretofore been the almost fatally flawed DSM 5 process.

    The smart play for them now is also the only right thing to do. APA should, like Bob, come clean that many mistakes have been made and that it will take the time and make the effort to correct them. APA should cancel the arbitrary DSM 5 publication date and continue to work on DSM 5 until it can produce a quality document. It should drop the proposals that have drawn such widespread opposition or open them up to independent scientific review. Someone who can write clean and consistent criteria sets should be recruited and, after the badly needed editing is completed, previously poorly performing criteria sets need to be retested.

    Unless it delays and reforms DSM 5, the new leadership will be left holding the bag- having to defend the truly indefensible when a fourth-rate DSM 5 is published next May. The new leaders are not responsible for this mess and don't deserve to be the butt of the harsh criticism that will follow. But if they don't fix DSM 5, they will own it and be tainted by it.

    APA should clean the DSM 5 house now before it is too late. Were he alive today that's what Mel Sabshin, its long term and much revered leader, would certainly recommend.

    And Bob Spitzer has shown the way. A clear parallel can be drawn between Bob's openly apologizing and withdrawing his paper and the need for APA to apologize and to withdraw its untenable proposals, end its closed process, and drop its slavish adherence to unrealistic timelines.

    If a legendary figure like Bob can correct his mistakes, surely the APA can do the same- for the sake of protecting our patients and keeping the mental health field united.

    There is always regret for having made errors along the way, but the far greater shame is in pressing forward when your own results reveal them. Inertia is one of the most powerful forces in nature -it takes real courage to oppose it. If APA changes gears, none of us is going to say, “I told you so!” We're going to applaud and feel proud that APA is finally on the right track. As with Bob Spitzer, sometimes the greatest honor is to admit mistakes and do the very best we can to correct them.

    If it fails to reform DSM 5 now, the APA leadership will have much more to apologize for in the future- to its members, to our colleagues, and of course most important to our patients.

    New York Has Some Prisons to Sell You - NYTimes

    New York wants to sell the former Oneida Correctional Facility in Rome, but for now, no one is using the prison or its amenities, like a handball court.
    Nathaniel Brooks for The New York Times

    New York Has Some Prisons to Sell You

    Since tactics like freezing state workers’ wages didn’t help budget problems, Gov. Andrew M. Cuomo is trying a new tactic. Above, the former Oneida Correctional Facility.

    Thursday, May 24, 2012

    Psychiatry’s internal war over “mental illness” unhinges everything « The Teeming Brain

    Psychiatry’s internal war over “mental illness” unhinges everything « The Teeming Brain

    Psychiatry’s internal war over “mental illness” unhinges everything

    Posted: May 23, 2012 in Society & Culture
    Tags: , , ,

    Have you or anybody you care about ever suffered from depression? How about bipolar disorder? Autism? Schizophrenia? Attention-deficit disorder? Obviously, given the prevalence of these mental and neurological illnesses, the answer is almost certainly affirmative.
    Or then again, maybe not. Here’s the dirty little trick that’s been pulled over on all of us: each of those illnesses is a wholesale semantic/cultural invention, concocted out of thin air, that deserves to be put in scare quotes. And this, of course, imparts a whole new tone to them. Think about it: there’s an entirely different feeling when you say somebody suffers from “depression” or “ADD.” For full effect, imagine translating the scare quotes into the now-trendy “air quotes.” In fact, why not try it out. Say the words out loud and make the quotation marks with your fingers: “depression,” “autism,” “bipolar disorder,” “attention-deficit disorder,” “schizophrenia.” Feel the irony now coating these familiar psychiatric terms. Note how they no longer seem so familiar or meaningful, how they no longer seem to signify something literally real.
    If you’ve successfully achieved this disorienting act of linguistic dislocation and decontextualizing, then you’ve begun to deprogram yourself and wake up from the spell of cultural hypnosis that’s been cast over us all by the American Psychiatric Association and Big Pharma. And that’s not just me talking; it’s actual members of the APA, including, most significantly, the lead editor of the DSM-IV, the fourth edition of the APA’s Diagnostic and Statistical Manual (see the linked and excerpted articles below).
    The DSM is, in the words of one of the items below, “as important to psychiatrists as the Constitution is to the US government or the Bible is to Christians.” This is because it’s the official manual that lays out the APA’s official definitions of mental illnesses and the criteria for diagnosing them. I was first introduced to it personally when I worked as a producer of video courses for Missouri State University in the 1990s. The job entailed attending and videotaping every classroom meeting of various live, lecture-based college courses, and then spending months transforming them into video versions of themselves with the help of computer graphics, music beds, and creative editing. This meant I got to know these classes better than any of the enrolled students, and one of them was a social work class about substance abuse intervention that involved regular references to the DSM-IV. Spending six or eight months making that course burned into my mind the implicit understanding that this book is truly the Holy Scripture of mental illness, because the instructor referred to it at least one or two times in every lecture.
    But the thing is — and I didn’t wake up to this until some years later — psychiatry as a formal profession really has no idea what constitutes mental illness, nor does it know what constitutes mental health, for the simple reason that it doesn’t know what the soul — the “psyche” in psychiatry and psychology — really is, does, means, or ought to be. And this is the dirty little not-so-secret that lies not just at the heart of psychiatry but at the heart of every one of the so-called human sciences. How is it that we ever came to think “science” in its modern-day iteration as “the study of empirically testable and verifiable phenomena” is applicable to the realms of human society and personal reality anyway? Where exactly does psychiatry, formally defined as a medical field and thus a “hard” science, diverge from the “soft” science of psychology or any other “social science”? If there’s a controversy going on in the area of consciousness studies right now (as indeed there is) about whether consciousness really boils down to the brain or is something else, something wider, then how did the biomedical model of psychiatry ever become the supreme reigning orthodoxy in modern technological society? The answer is simple: it became so by sheer assertion, by default assumption, and by the imposition of the anti-metaphysical claim of biomedical materialism (which is of course a metaphysical position in itself) onto the study of the human self. In other words, and to widen the frame a bit, it happened as part of the ongoing takeover (hijacking) of “mainstream thought” by fundamentalist materialism wedded to economic materialism that has characterized modern society ever since the epochal transformations of the scientific revolution and Age of Enlightenment.
    In the 1960s and 70s, Alan Watts, one of my most beloved authors and primary philosophical influences, wrote and lectured regularly about the fact — the fact, mind you, not the ideologically motivated assertion — that the psychiatric and psychological professions as formally practiced literally have no idea what they’re doing. (And of course he wasn’t alone in this, as the example of R.D. Laing, to name just one notable spokesperson for the anti-psychiatry movement, shows.) Watts once wrote,
    The publication of my Psychotherapy East and West and Joyous Cosmology early in the sixties brought me into public and private discussion with many leading members of the psychiatric profession, and I was astonished at what seemed to be their actual terror of unusual states of consciousness. I had thought that psychiatrists should have been as familiar with these wildernesses and unexplored territories of the mind as Indian guides, but as I perused something like the two huge volumes of The American Handbook of Psychiatry, I found only maps of the soul as primitive as ancient maps of the world. There were vaguely outlined emptinesses called Schizophrenia, Hysteria, and Catatonia, accompanied with little more solid information than “Here be dragons and cameleopards.”
    – Alan Watts, “The Soul-Searchers,” excerpted from his In My Own Way: An Autobiography, 1915-1965 (1972)
    This isn’t just a problem from the past. The “emperor has no clothes” situation that Watts identified in the psychiatric profession half a century ago is still with us today, only more so, because today we are, if possible, even more overtaken and programmed and hypnotized by the false idea that psychiatry and psychology actually proceed on a basis of assured and verified knowledge. And this means we live even more fully under the sway of falsely conceived ideas about our very souls and subjectivities that are forced upon us from without like mental-spiritual straitjackets. Hence the almost universal, casual, workaday acceptance of the ideas of “depression” and all the rest. All of them, to repeat, are invented concepts, not discovered realities. Entrenched and sometimes debilitating sadness and lethargy, and the draining of happiness or even the ability to experience it — what used to be called “melancholia” — is a reality. But the label “major depression” and all that goes with it is a made-up concept that falsely implies psychiatrists really know what they’re dealing with. A high amount of jumpiness and nervous energy accompanied by a rapidly shifting focus of attention are experienced by a lot of people, but to call them “ADD” or “ADHD” is a sleight-of-hand maneuver that falsely reifies them and binds them together into a supposed illness. Hearing voices and experiencing a kind of volcanic uprush of sensory and mental-emotional activity from an apparently internal source in the psyche that feels separate and autonomous from one’s conscious self is as old as the human race itself, but to medicalize the experience by labeling it “schizophrenia” and then proceed on the idea that it requires drug-based treatment (which does, yes, prove helpful to some people) is to flat-out lie by saying the condition’s basic nature is scientifically understood even if its exact causes aren’t. (Who can confidently claim — as in truly, authoritatively, reasonably — that the psychiatric profession’s medicalized clampdown on this perennial human experience is any more valid than, say, Philip K. Dick’s assertion that “The schizophrenic is a leap ahead that failed”?)
    For people who have never begun the journey down this path of mental deprogramming, it can be very difficult to get a handle on it and really feel the true depth of its earth-shattering implications, which center around the fact that the very view of human life — yours, mine, everybody’s, up-close and personal — and the nature of reality that we collectively share in our post-industrial techno-dystopia is shot through with arbitrary scientistic bullshit. The “official” (note the scare quotes) line about who and what we are, and who and what life is, is a scam, a snow job, a line we’ve been fed along with a spoonful of sugar about its supposedly solid status to help the medicine go down. There is no more intimate and comprehensive locus from which to arbitrate these kinds of all-encompassing, axiom-level notions than the psyche itself, the center-point of our individual perspectives. Blast the reigning assumptions and dogmas there, and the entire world radiating outward from them begins to crack apart.
    As a starting point, I advise reading the following extended excerpts from various recent writings about the psychiatric profession’s internal war over the imminent new revision — the first in nearly 20 years — of the DSM. I’ve also included a couple of excellent pieces from The New York Review of Books about the deep history of how we arrived at the current biomedical model of mental illness, and why this development was very conscious, very illogical, and very driven, in part, by an unholy alliance between the psychiatric profession and what, with their help, became today’s Big Pharma.
    James Howard Kunstler recently published a couple of blog posts (“Juked by Medicine” and “Matrix of Rackets“) about an unpleasant and thoroughly disillusioning experience he had with his doctor. In one of them he said, “I wonder if doctors are losing their legitimacy now in a way similar to the other authority figures in our culture: the political leaders, the bankers economists, the business executives.” The answer, of course, is yes, and this is something I assert based not only on hearsay but on recent and ongoing experiences that my family and friends have had with doctors and medical institutions. And the same point extends, clearly and incontrovertibly, to the psychiatric and psychological professions as well. All bets, as they say, are now off.
    * * *
    Trouble at the Heart of Psychiatry’s Revised Rule Book
    Edward Shorter (historian of psychiatry, University of Toronto), Streams of Consciousness, Scientific American, May 9, 2012
    One might liken the latest draft of psychiatry’s new diagnostic manual, the DSM-5, to a bowl of spaghetti. Hanging over the side are the marginal diagnoses of psychiatry, such as attention deficit hyperactivity disorder and autism, important for certain subpopulations but not central to the discipline. At the center of the spaghetti bowl are the diagnoses at the heart of psychiatry: major depression, schizophrenia, bipolar disorder… The main difficulty is that the principal diagnoses of psychiatry are artifacts…[Major depression was created by] lumping…two forms of depressive illness together. In fact, they are so disparate that the depression term itself should be abandoned. It is now shopworn with use and has approximately the same scientific value as other discarded psychiatric diagnoses such as hysteria and madness…There is no natural disease entity called schizophrenia: it has no typical, or pathognomonic, symptom, no predictable response to treatment, no reliable prognosis. Chronic psychosis is really a common final pathway for several disparate forms of psychotic illness that should not be lumped together…[L]umping] all [forms of chronic psychosis] together commits the same error as lumping together melancholia and nonmelancholia…The third fatal flaw at the center of the bowl of spaghetti is bipolar disorder, a diagnosis that assumes that the depression of unipolar disorder (otherwise known as major depression) is different from bipolar depression. But they’re really the same…And the entire concept of bipolar disorder has been a gift to the pharmaceutical industry, which has been able to re-position anticonvulsant drugs to counter the terrible bipolar menace.
    * * *
    Inside the Battle to Define Mental Illness
    Gary Greenberg, Wired, December 27, 2010
    “We made mistakes that had terrible consequences [in the DSM-IV]” [says Allen Frances, the edition's lead editor]. Diagnoses of autism, attention-deficit hyperactivity disorder, and bipolar disorder skyrocketed, and Frances thinks his manual inadvertently facilitated these epidemics — and, in the bargain, fostered an increasing tendency to chalk up life’s difficulties to mental illness and then treat them with psychiatric drugs…The insurgency against the DSM-5 (the APA has decided to shed the Roman numerals) has now spread far beyond just Allen Frances. Psychiatrists at the top of their specialties, clinicians at prominent hospitals, and even some contributors to the new edition have expressed deep reservations about it….At stake in the fight between Frances and the APA is more than professional turf, more than careers and reputations, more than the $6.5 million in sales that the DSM averages each year. The book is the basis of psychiatrists’ authority to pronounce upon our mental health, to command health care dollars from insurance companies for treatment and from government agencies for research. It is as important to psychiatrists as the Constitution is to the US government or the Bible is to Christians…What the battle over DSM-5 should make clear to all of us — professional and layman alike — is that psychiatric diagnosis will probably always be laden with uncertainty, that the labels doctors give us for our suffering will forever be at least as much the product of negotiations around a conference table as investigations at a lab bench.
    * * *
    The Epidemic of Mental Illness: Why?
    Marcia Angell, The New York Review of Books, June 23, 2011
    The shift from “talk therapy” to drugs as the dominant mode of treatment coincides with the emergence over the past four decades of the theory that mental illness is caused primarily by chemical imbalances in the brain that can be corrected by specific drugs. That theory became broadly accepted, by the media and the public as well as by the medical profession, after Prozac came to market in 1987 and was intensively promoted as a corrective for a deficiency of serotonin in the brain…What is going on here? Is the prevalence of mental illness really that high and still climbing?…On the other hand, are we simply expanding the criteria for mental illness so that nearly everyone has one?…In the space of three short years…drugs had become available to treat what at that time were regarded as the three major categories of mental illness — psychosis, anxiety, and depression — and the face of psychiatry was totally transformed…[I]nstead of developing a drug to treat an abnormality, an abnormality was postulated to fit a drug. That was a great leap in logic…“By this same logic one could argue that the cause of all pain conditions is a deficiency of opiates, since narcotic pain medications activate opiate receptors in the brain.” Or similarly, one could argue that fevers are caused by too little aspirin…[B]ecause the positive studies were extensively publicized, while the negative ones were hidden, the public and the medical profession came to believe that these drugs were highly effective antidepressants…[E]ven as drug treatment for mental illness has skyrocketed, so has the prevalence of the conditions treated…”Could our drug-based paradigm of care, in some unforeseen way, be fueling this modern-day plague?”…[T]he natural history of mental illness has changed. Whereas conditions such as schizophrenia and depression were once mainly self-limited or episodic, with each episode usually lasting no more than six months and interspersed with long periods of normalcy, the conditions are now chronic and lifelong. Whitaker believes that this might be because drugs, even those that relieve symptoms in the short term, cause long-term mental harms that continue after the underlying illness would have naturally resolved.
    * * *
    The Illusions of Psychiatry
    Marcia Angell, The New York Review of Books, July 14, 2011
    [T]he medical director of the American Psychiatric Association (APA), Melvin Sabshin, declared in 1977 that “a vigorous effort to remedicalize psychiatry should be strongly supported,” and he launched an all-out media and public relations campaign to do exactly that. Psychiatry had a powerful weapon that its competitors lacked. Since psychiatrists must qualify as MDs, they have the legal authority to write prescriptions. By fully embracing the biological model of mental illness and the use of psychoactive drugs to treat it, psychiatry was able to relegate other mental health care providers to ancillary positions and also to identify itself as a scientific discipline along with the rest of the medical profession. Most important, by emphasizing drug treatment, psychiatry became the darling of the pharmaceutical industry, which soon made its gratitude tangible…Not only did the DSM become the bible of psychiatry, but like the real Bible, it depended a lot on something akin to revelation. There are no citations of scientific studies to support its decisions. That is an astonishing omission, because in all medical publications, whether journal articles or textbooks, statements of fact are supposed to be supported by citations of published scientific studies…”A powerful quartet of voices came together during the 1980’s eager to inform the public that mental disorders were brain diseases. Pharmaceutical companies provided the financial muscle. The APA and psychiatrists at top medical schools conferred intellectual legitimacy upon the enterprise. The NIMH [National Institute of Mental Health] put the government’s stamp of approval on the story. NAMI provided a moral authority”…[The psychiatric profession is currently beset by a] “frenzy” of diagnosis, the overuse of drugs with sometimes devastating side effects, and widespread conflicts of interest.
    * * *
    ‘Label jars, not people’: Lobbying against the shrinks
    James Davies, New Scientist, May 17, 2012
    “Label jars, not people” and “stop medicalising the normal symptoms of life” read placards, as hundreds of protesters — including former patients, academics and doctors — gathered to lobby the American Psychiatric Association’s (APA) annual meeting. The demonstration aimed to highlight the harm the protesters believe psychiatry is perpetrating in the name of healing. One concern is that while psychiatric medications are more widely prescribed than almost any drugs in history, they often don’t work well and have debilitating side effects. Psychiatry also professes to respect human rights, while regularly treating people against their will. Finally, psychiatry keeps expanding its list of disorders without solid scientific justification. At the heart of the issue is the Diagnostic and Statistical Manual of Mental Disorders (DSM) — psychiatry’s diagnostic “bible.” Allen Frances, who headed the last major rewrite of the manual — DSM-IV — fears that the revised version will undermine the profession’s credibility. “What concerns me most,” he says, “is that its publication will dramatically expand the realm of psychiatry and narrow the realm of normality.”